Intrasphincteric Botulinum toxin (BoTox) injection for symptomatic postoperative anal achalasia in Hirschsprung's disease (HSCR) has found wide application in the last twenty years. The aim of this study is to describe effectiveness and functional outcome of a series of patients treated over a 10-year period.
-
2018 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
Introduction: The association of Hirschsprung disease (HSCR) and Down Syndrome (DS) is not uncommon (HSCR + DS). This paper aims at reporting the results of a 24-year series focusing on surgical approach, complications and long term outcome. Materials and methods: The notes of all patients admitted with a diagnosis of HSCR + DS have been...
Uploaded on: April 14, 2023